Nuveen Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $36.6M | Sell |
267,980
-77,597
| -22% | -$10.6M | 0.01% | 808 |
|
|
2024
Q3 | $39.8M | Sell |
345,577
-1,916
| -0.6% | -$221K | 0.01% | 771 |
|
|
2024
Q2 | $47.8M | Sell |
347,493
-9,701
| -3% | -$1.34M | 0.01% | 646 |
|
|
2024
Q1 | $49.3M | Sell |
357,194
-3,329
| -0.9% | -$459K | 0.01% | 638 |
|
|
2023
Q4 | $47.5M | Sell |
360,523
-4,535
| -1% | -$598K | 0.02% | 624 |
|
|
2023
Q3 | $41.1M | Buy |
365,058
+40,884
| +13% | +$4.6M | 0.01% | 637 |
|
|
2023
Q2 | $30.6M | Buy |
324,174
+80,416
| +33% | +$7.58M | 0.01% | 815 |
|
|
2023
Q1 | $24.7M | Sell |
243,758
-4,063
| -2% | -$411K | 0.01% | 902 |
|
|
2022
Q4 | $29.6M | Sell |
247,821
-32
| -0% | -$3.82K | 0.01% | 805 |
|
|
2022
Q3 | $26.3M | Sell |
247,853
-6,938
| -3% | -$737K | 0.01% | 844 |
|
|
2022
Q2 | $24.8M | Buy |
254,791
+5,529
| +2% | +$539K | 0.01% | 896 |
|
|
2022
Q1 | $23.5M | Buy |
249,262
+4,453
| +2% | +$419K | 0.01% | 1087 |
|
|
2021
Q4 | $20.9M | Sell |
244,809
-33,700
| -12% | -$2.87M | 0.01% | 1211 |
|
|
2021
Q3 | $26.7M | Sell |
278,509
-87,751
| -24% | -$8.42M | 0.01% | 1068 |
|
|
2021
Q2 | $35.6M | Sell |
366,260
-84,124
| -19% | -$8.19M | 0.01% | 944 |
|
|
2021
Q1 | $43.8M | Sell |
450,384
-15,901
| -3% | -$1.55M | 0.01% | 800 |
|
|
2020
Q4 | $44.7M | Sell |
466,285
-90,204
| -16% | -$8.65M | 0.02% | 747 |
|
|
2020
Q3 | $53.5M | Sell |
556,489
-33,108
| -6% | -$3.18M | 0.02% | 557 |
|
|
2020
Q2 | $71.9M | Sell |
589,597
-31,719
| -5% | -$3.87M | 0.03% | 457 |
|
|
2020
Q1 | $53.8M | Sell |
621,316
-70,512
| -10% | -$6.1M | 0.03% | 475 |
|
|
2019
Q4 | $74.4M | Sell |
691,828
-115,889
| -14% | -$12.5M | 0.03% | 512 |
|
|
2019
Q3 | $72.8M | Buy |
807,717
+40,939
| +5% | +$3.69M | 0.03% | 495 |
|
|
2019
Q2 | $64.7M | Buy |
+766,778
| New | +$64.7M | 0.03% | 564 |
|
|
2017
Q2 | – | Sell |
-14,464
| Closed | -$626K | – | 1216 |
|
|
2017
Q1 | $626K | Buy |
14,464
+763
| +6% | +$33K | ﹤0.01% | 1112 |
|
|
2016
Q4 | $530K | Hold |
13,701
| – | – | ﹤0.01% | 1277 |
|
|
2016
Q3 | $694K | Buy |
13,701
+2,737
| +25% | +$139K | ﹤0.01% | 1153 |
|
|
2016
Q2 | $498K | Sell |
10,964
-22,643
| -67% | -$1.03M | ﹤0.01% | 1162 |
|
|
2016
Q1 | $1.33K | Sell |
33,607
-5,207
| -13% | -$206 | 0.01% | 909 |
|
|
2015
Q4 | $2.2K | Buy |
38,814
+8,132
| +27% | +$460 | 0.01% | 736 |
|
|
2015
Q3 | $1.22K | Sell |
30,682
-6,522
| -18% | -$260 | 0.01% | 956 |
|
|
2015
Q2 | $1.78K | Buy |
37,204
+1,532
| +4% | +$73 | 0.01% | 862 |
|
|
2015
Q1 | $1.42M | Buy |
+35,672
| New | +$1.42M | 0.01% | 978 |
|